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Abstract
Microcrystalline cellulose (MCC) is a pure partially depolymerized cellulose 
synthesized from α-cellulose precursor (type Iβ), obtained as a pulp from fibrous plant 
material, with mineral acids using hydrochloric acid to reduce the degree of polymer-
ization. The MCC can be synthesized by different processes such as reactive extrusion, 
enzyme mediated, steam explosion, and acid hydrolysis. It is commonly manufactured 
by spray-drying the neutralized aqueous slurry of hydrolyzed cellulose. The MCC is 
a valuable additive in pharmaceutical, food, cosmetic, and other industries. MMC 
obtained from different sources will differ considerably in chemical composition, 
structural organization, and physicochemical properties (crystallinity, moisture 
content, surface area and porous structure, molecular weight, etc.). The high demand 
of microcrystalline cellulose used in pharmaceutical industries has led to the utiliza-
tion of locally and naturally occurring materials in the production of microcrystalline 
cellulose. Many studies on the physicochemical properties of locally produced MCC 
derived from natural sources have been extensively evaluated in the development of a 
new natural source for MCC as a substitution of wood, the most abundant one.
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1. Introduction
Cellulose, a fibrous carbohydrate found in all plants, is the most abundant 
natural polymer with biomass production of 50 billion tons per year [1]. Cellulose 
is a linear polymer of glucose. Based on solubility in alkaline, cellulose is divided 
into three groups which are alpha, beta, and gamma celluloses. Microcrystalline 
cellulose (MCC) is a purified, partially depolymerized cellulose having the formula 
(C6H10O5)n. It is prepared by treating alpha cellulose with mineral acids (type Ib). 
This polysaccharide polymer consists of a linear chain of several hundred to over 
ten thousand β(1 → 4) linked D-glucose units, consisting of linear chains of β-1,4-d 
anhydroglucopyranosyl units. Raw material used for MMC preparation is a pulp 
from a fibrous plant such as conifer wood. Cotton is also a possible cellulose source 
for MCC [2, 3]. Pharmaceutical grade MCC, which needs a high-quality pulp, used 
wood as the most common source. From such wooden source, cellulose chains 
are packed in layers and held together by strong hydrogen bonds from lignin, a 
cross-linking polymer. For that purpose, both softwoods (evergreen conifer) and 
hardwoods (deciduous broadleaf) can be used [4]. These woods differ not only in 
chemical composition including cellulose proportions, hemicelluloses, and lignin 
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but also in structural organization, i.e., regions which are relatively more crystalline 
or amorphous. The amorphous regions are more prone to hydrolysis by acid result-
ing in shorter and more crystalline fragments.
Non-woody lignocellulosic materials have also been developed as source of MCC 
such as cotton linters [5], cotton stalks [6], cotton rags [5], cotton fabric waste [7], 
cotton wool [8], soybean husk [9], corn cob [10], water hyacinth [11], coconut 
shells [12], oil palm biomass residue [13, 14], oil palm fronds [15], rice husk [6, 16], 
sugar cane bagasse [6, 16–20], jute [21, 22], ramie [23], fibers and straw of flax [24], 
wheat straw [25], sorghum stalks [26], sisal fibers [27] and mangosteen [28], alfa 
grass fibers [29, 30], soybean hulls [31], orange mesocarp [32], Indian bamboo [33], 
roselle fiber [34], and alfa fiber [35]. Seed flosses from milkweed pods (Calotropis 
procera), shrubs, and kapok (Ceiba pentandra) trees are also known as cellulosic 
resources. Due to its high purity of alpha cellulose, most seed flosses must be treated 
to remove impurities including lignin, pectin, and wax [36].
Wooden sources contain cellulose chains which are packed as layers held by 
cross-linking hydrogen bonds [37]. Chemically it consists of polymeric matrix of 
lignin, hemicelluloses, and pectin [38]. Different woods considerably possessed dif-
ferent chemical composition of cellulose (including allocations of cellulose, hemi-
celluloses, and lignin in cell wall) and structural organization as well. Relatively 
different crystallinity in particular regions is observed as more amorphous accord-
ing to softwoods (evergreen conifer) and hardwoods which are termed as deciduous 
broadleaf [4, 37]. The amorphous regions of cellulose provide a more susceptible 
property for depolymerization by acid hydrolysis. At optimum acid concentration, 
the process gave shorter and more crystalline fragments such as the MCC [2, 37].
2. Synthesis of MCC
The MCC can be synthesized by different processes including extrusion and 
enzyme-mediated process [25]. Other studies reported that it can also be synthe-
sized by steam explosion and acid hydrolysis process [5, 6]. The acid hydrolysis 
process is more preferable due to shorter duration than others. It also offered the 
possibility to be applied as a continuous process rather than a batch-type process. 
Limited quantity of consumed acid is also the advantage of the process, while, 
despite the lower unit cost from less chemicals used, this process offered more fine 
particles of the MCC as the final product [5]. Fibrous plant pulp is hydrolyzed by 
mineral acid under heat and pressure. In the presence of water and acid, hydrolysis 
process breaks cellulose polymers into smaller chain polymers or microcrystals. 
Other celluloses, to which soluble components of cellulose such as beta and gamma 
celluloses, hemicelluloses, and lignin are dissolved with acid and water, are sepa-
rated out during washing process by water which continued by filtration. The 
obtained pure alpha cellulose has then been neutralized and given the slurry final 
product [3]. This suspension is dried to obtain the insoluble white, odorless, taste-
less powder, which has later been characterized as MCC [39]. MCC is hygroscopic in 
nature, and insoluble in water, but swells when in contact with water.
Another synthesis procedure of the MCC reported by Ohwoavworhua et al. [40] 
can be concluded as follows: the α-cellulose was hydrolyzed with hydrochloric acid 
at a boiling temperature of 105° for 15 min. The neutralized slurry obtained from 
the hydrolysis process was washed, and the fraction passing through 710 μm sieve 
was stored at room temperature in a desiccator. MCC is commonly dried from the 
slurry by spray-drying method. By varying spray-drying conditions, the degree of 
agglomeration and moisture content can be manipulated. In order to obtain smaller 
particle sizes (below 50 μm), further milling MCC can be performed [1].
3Microcrystalline Cellulose as Pharmaceutical Excipient
DOI: http://dx.doi.org/10.5772/intechopen.88092
Other drying techniques may be used, which may require additional screening 
steps postdrying in order to control particle size distribution [41, 42]. Higher bulk 
density grades are also available by using specific cellulose pulps (raw material), 
and median particle sizes below 50 mm can be obtained by further milling MCC [1].
Several studies have compared microcrystalline cellulose with various sources, 
including different manufacturers and different sites [4, 43–47]. MCC produced 
by various manufacturers or in various manufacturing sites may have different 
properties due to the kinds of pulp used as raw materials and their respective 
manufacturing conditions [2, 4]. A number of studies have confirmed that the 
moisture content of MCC influences compaction properties, tensile strength, and 
viscoelastic properties [48].









HCl 2 N 10:1 105 15 n.a [5]
HCl 2 N 10:1 45 15 n.a [6]
HCl 2.5 N 20:1 85 90 80 [5]
HCl 2.5 N 62.5:1 105 15 19 [6]
HCl 2 N 10:1 n.a 45–60 n.a [7]
Table 1. 
Hydrolysis reagents (acid type and concentration), liquor to cellulose ratio (L/C), hydrolysis conditions, and 









50 It is most widely used for direct compression tableting, for wet granulation, for 
spheronization, and in capsule filling processes
PH 
102
100 It is used as the PH-101, but its larger particle size improves the flow of fine powders
PH 
103
50 It has the same particle size as PH-101 with lower moisture content (3%), so it is 





It is the most compressible of the PH products owing the smallest particle size. Well 
known as excipient for direct compression for granular or crystalline materials. 
When mixed with PH-101 or PH-102, specific flow and compression characteristics 
will be obtained. It has applications in roller compaction
PH 
112
100 It has the same particle size as PH-102. It has lower moisture content (1.5%). It is 
used for high moisture-sensitive pharmaceutical active ingredients
PH 
113
50 It has the same particle size as PH-101. It has lower moisture content (1.5%). It is 
used for high moisture-sensitive pharmaceutical active ingredients
PH 
200
180 It has a large particle size with increased flowability. It is used to reduce weight 
variation and to improve content uniformity in direct compression formulations 
and in wet granulation formulations
PH 
301
50 It has the same particle size as PH-101 but is denser providing more flowability and 
tablet weight uniformity. Useful for making smaller tablets and in capsule filling 
excipient
Table 2. 
Types of the commercial microcrystalline cellulose [1, 51].
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It was generally recognized that batch-to-batch variability from a sole manu-
facturing site was less important than differences observed between multiple 
sources. Only a few studies have tried to correlate the manufacturing conditions of 
microcrystalline cellulose with its physicochemical properties and its performance 
in tableting applications [2, 49, 50]. The effect of some parameters on hydrolysis 
process on yield value of production is shown in Tables 1 and 2.
3. Physicochemical properties of MCC
3.1 Moisture content
A number of studies have confirmed that the moisture content of MCC influ-
ences compaction properties, tensile strength, and viscoelastic properties [48, 52, 53]. 
Moisture within the pores of MCC may act as an internal lubricant, reduce frictional 
forces, and facilitate slippage and plastic flow within the individual microcrystals 
[54, 55]. The lubricating properties of water may also reduce tablet density variation 
by providing a better transmission of the compression force through the compact 
and by decreasing the adhesion of the tablet to the die wall [55, 56]. Compressibility 
of MCC depends on moisture content, which means that when MCC having differ-
ent moisture content is compressed with the same pressure, it may not result in the 
same compact porosity. It is very well known that compaction pressure required to 
produce certain porosity (or solid fraction) decreases with increasing moisture con-
tent. Sun reported that below 3% water content, the compaction properties of MCC 
were insensitive to variation of moisture [53]. However up to an optimum level, an 
increase of moisture will increase the tablet strength of most excipients. This can be 
explained by the fact that molecular binding in water vapor layers reduces interpar-
ticular surface distances, hence increasing intermolecular attraction forces [56].
The storage conditions of the MCC compacts also play an important role, 
as an increase in relative humidity will negatively impact tablet strength [47]. 
However this softening is often reversible when tablets are removed from the 
humid environment [1]. Fundamental forces affecting powder flow are cohesion 
and friction [55]. Frictional forces and electrostatic charges between particles 
during the compression process will decrease as moisture content increases. 
Moisture may also play a role in increasing cohesion forces inside particles due 
to the creation of liquid or even solid bridges. In the case of MCC as excipient, 
significant changes in flowability were observed when increasing moisture 
contents were applied which resulted in changes in powder cohesiveness. This 
phenomenon was described by the increase in compressibility index and the 
shear cell [48].
3.2 Particle size
Particle size has a very little effect on the tabletability of neat MCC, i.e., not 
lubricated nor blended with other excipients or active pharmaceutical ingredients 
(APIs) [57–60]. MCC particle size and moisture content are often considered as the 
most important CMAs for tableting performance [61]. Considering that the brittle-
ductile transition diameter (Dcrit) of MCC is 1949 mm, standard MCC grades, 
having particle sizes below Dcrit, should all deform plastically when compression 
pressure exceeds yield pressure. Coarser grades of MCC, characterized by a smaller 
envelope surface area, have been reported to be more lubricant sensitive than 
finer MCC [52, 58, 62, 63]. In complete formulations finer MCCs would therefore 
promote tablet (compact) strength [64, 65]. Reducing the particle size of MCC 
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will increase cohesiveness and hence as a consequence surely affect its flowability. 
Kushner et al. reported that different particle sizes of excipient may impact tablet 
characteristics including hardness, friability, disintegration, and content uniformity 
[66]. Improved flowability will be obtained when coarser MCCs are employed as 
well as reduction in tablet weight variation [67]. Hlinak et al. suggested that particle 
size may also impact wetting properties, dissolution of the API, and stability of 
drug products [68].
Albers et al. evaluated the tableting properties of three batches from five 
different brands MCC type 101 [43]. Batches using single manufacturer source 
produced more similar tablet characteristic than those using samples from vari-
ous sources. Statistically significant differences were also observed within single 
brands of MCC. From a different batch of MCC studied, the greatest differences in 
powder properties were observed in the median particle size and specific surface 
area. Despite the lower median particle size of Avicel PH-101 (FMC), this MCC 
was described as easy flowing powder compared to other brands as illustrated by its 
low compressibility index and high values of shear cell flow functions (FFc) which 
exceed 4.
Williams et al. used tableting indices to investigate the compaction properties 
of MCC types 101 and 102 (median particle size of about 50 and 100 mm, respec-
tively), each type being represented by two batches from five different sources [47]. 
The lubricant sensitivity of MCC expressed as its compressibility decreased when 
this excipient was mixed with other materials such as magnesium stearate. Another 
factor affecting lubricant sensitivity of MCC is the particle size. A higher particle 
size of MCC, Avicel PH-200 (180 microns), is more sensitive to lubricant than 
Avicel PH-101 (50 microns). At the same concentration, the lubricant covers more 
efficiently a larger particle size of MCC (PH-200) than that of the smaller particle 
size of MCC (PH-101) due to a larger particle surface area of smaller particles of 
MCC [51].
Compactability of the MCC particles is affected by the porosity. Avicel PH-101, 
Avicel PH-102, and Avicel PH-200 as marketed products of MCC owing almost 
the same density showed the same compressibility despite their mean particle 
size which varies from 50 to 180 microns. Avicel PH-301 (50 microns) and Avicel 
PH-302 (90 microns) which physically are more dense revealed less compressible or 
compactable properties [51].
3.3 Particle morphology
Obae et al. suggested that MCC morphology, described by the length of particles 
(L) and their width (D), was one of the most important factors influencing tablet-
ability [69]. Rod-shaped particles which are fibrous and having higher L/D ratios 
resulted in higher tablet strengths than round-shaped particles. Other physico-
chemical properties of MCC including moisture content, bulk density, and specific 
surface area did not correlate well with tensile strength of obtained tablet. Obae 
et al. illustrated the reduction of bulk density and flowability and the increase of 
specific surface area when the L/D ratio increased. This may be due to the property 
of the particles which is more fibrous. MCC morphology was found to be affecting 
the drug dissolution which may due to porosity [70].
3.4 Crystallinity
Modifying the hydrolysis conditions, including temperature, time, and acid 
concentration, also has a very little impact on the degree of crystallinity, i.e., 
the regularity of the arrangement of the cellulose polymer chains [2, 50]. This 
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observation indicates that crystallinity cannot be controlled at the hydrolysis 
stage. Crystallinity appears to be more dependent on pulp source rather than on 
processing conditions [4], which is consistent with the method of MCC manu-
facture where the acid preferentially attacks the (pulp dependent) amorphous 
regions.
The total amount of sorbed water in MCC is proportional to the fraction of 
amorphous material [48, 54, 55]. Therefore MCC powders with a lower degree of 
crystallinity may contain more water than their counterparts with a higher degree. 
If low-crystallinity MCC preferentially binds more water, moisture-sensitive APIs 
may exhibit lower rates of degradation [71]. Despite the controversial impact of 
crystallinity, it may influence the adsorption of water on cellulose microfibrils, 
which may in turn influence flowability, tabletability, and stability of the drug 
product.
3.5 Bulk density
Mostly, direct compression excipients are spray-dried; therefore porous struc-
ture was produced as a result. This property is characterized by a relatively low 
bulk density. Increase in porosity (lower density) facilitates higher compressibility, 
i.e., the densification of a powder bed due to the application of a stress [56]. The 
improved compressibility of plastically deforming materials, such as MCC, might 
then result in improved tabletability as a result of the increased bonding surface 
area [72]. The higher roughness of low density MCC particles may also contribute 
to particle interlocking [73]. Low bulk density MCC will provide higher dilu-
tion potential and hence better counteract the poor tableting properties of APIs. 
Granulation or drying as preprocesses of tablet formulation will densify MCC hence 
less tabletable than the original porous MCC [74, 75]. It can therefore be generalized 
that a decrease in bulk density improves tabletability; however, it will often hinder 
flowability [62].
3.6 Degree of polymerization
The degree of polymerization (DP) expresses the number of glucose units 
(C6H10O5) in the cellulose chain. It decreases exponentially as a function of hydro-
lysis conditions, including temperature, acid concentration, and time of reaction. 
The rate of hydrolysis slows down to a certain value which is stated as level-off 
degree of polymerization (LODP). The LODP value is specific for a particular pulp, 
and it is usually between the range of 200 and 300 [44, 61], e.g., 180–210 range for 
hardwood pulps and 210–250 for softwood pulps. Theoretically, to obtain a certain 
degree of polymerization which is higher than the LODP value, hydrolysis process 
could be terminated at any time. However, due to the exponential decay of DP, this 
termination is neither a robust nor a reproducible approach. The degree of polymer-
ization is used as an identity test, as pharmacopoeial MCC is defined by a DP below 
350 glucose units, compared to DPs in the order of 10,000 units for the original 
native cellulose [1].
The correlation between the degree of polymerization (DP) of MCC and its 
tabletability has not been explored yet. Therefore, it is merely an identity test to 
distinguish the tabletability of MCC (DP < 350) compared with powdered cellulose 
(DP > 440). Dybowski showed that the origin of the raw materials and the produc-
tion method of MCC more decisively influence the physical characteristics than 
DP. DP value is a criterion used to guide the manufacturer about hydrolysis of MCC, 
whereas for the user it is a characteristic to distinguish between properties of MCC 
and powdered cellulose.
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Wood pulps with high bulk density grades which can be characterized by lower 
level-off DP should not be directly compared with standard grades. This parameter 
reflects the lack of distinction between the degree of polymerization (DP) and 
level-off degree of polymerization (LODP). LODP is typical of a particular raw 
material, with a common value between the range of 200 and 300 [44]. Cellulose 
having LODP value at this range usually difficult for further hydrolysis. In contrast, 
cellulose materials with DP values higher than the level-off degree of polymeriza-
tion plateau are more difficult to control due to their greater sensitivity to hydro-
lysis. Owing LODP above 200–300, the MCC remains to be more fibrous, which 
would result in a lower bulk density, with improved tabletability, but would hinder 
powder flow [49, 50]. Below the LODP MCC is less fibrous, denser, and less tablet-
able. Tabletability is not related to a particular DP value; as an example powdered 
cellulose has a higher DP than MCC but is not as tabletable [1].
3.7 Effect of lignin
Landín et al. compared four brands of MCC [45]. Different woods used as raw 
materials, i.e., hardwood versus softwood, suggested differences in lignin and 
hemicelluloses composition. The non-cellulose component has also significantly 
different manufacturing process intensities which resulted in variable suggestive 
composition and potentially varying qualities of product. Landín et al. found that 
lignin content increased the dissolution rate of prednisone [46]. Lignin being 
hydrophobic may alter cellulose–cellulose and/or cellulose–API interactions and 
hence drug release rate.
Thoorens et al. [37] studied that differences in packing and flow properties 
which are shown by scanning electron micrographs from Avicel PH-101 and 
Avicel PH-102 were attributed to differences in moisture content, particle shape, 
and particle size distribution. Tabletability which also varied among the MCC 
samples were attributed to the differences in moisture content and the internal 
structure of the particles. These are mostly caused by different processing condi-
tions which are specific to each manufacturer. However, the impacts of crystal-
linity and particle morphology are negligible. Significant differences in lubricant 
sensitivity, compressibility, and tablet disintegration were also noted between 
MCCs due to various manufacturing processes by different manufacturers. 
Variability between lots from the same manufacturer was found to give a smaller 
effect on properties of MCC product. A current study from Doelker concluded 
that even if all of various MCCs comply with compendial specifications, large 
differences still exist among them [44].
4. MCC as pharmaceutical excipients
According to the International Pharmaceutical Excipient Council (IPEC), 
excipients are the process aids or any substances other than the active pharmaceuti-
cal ingredient that are included in pharmaceutical dosage forms. The functionalities 
of excipient are to impart weight, consistency, and volume which allow accuracy of 
dose, improve solubility, and in the end increase stability. It can also be proposed to 
enhance bioavailability, modifying drug release and used in product quick identifi-
cation, increase patient acceptability, and facilitate dosage form design.
Excipients classified as:
1. Primary excipients: diluents (filler), binders (adhesives), disintegrants, 
lubricants, antiadhesives, glidants
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2. Secondary excipients: coloring agents, flavors, sweeteners, coating agents, 
plasticizers wetting agents, buffers, and adsorbents
Diluents are incorporated into tablet or capsule dosage forms to increase dosage 
form volume or weight and can also be referred as fillers. Direct compression bind-
ers are functional even at low use levels and offer superior tabletability [1]. Some 
diluents, such as microcrystalline cellulose, can also be considered as dry binders 
since they improve the compactibility or tabletability of the compression mix.
Microcrystalline cellulose, according to many publications, is an excipient of 
outstanding merit and remains the most widely used direct compression excipient 
serving as a strong dry binder, tablet disintegrant, an absorbent, filler or diluent, a 
lubricant, and anti-adherent.
MCC is generally considered as the diluent having the best binding properties 
and is recognized as one of the preferred DC binders [44, 76]. It is used as a binder/
diluent in oral tablet and capsule formulations including both wet granulation and 
direct compression processes. It also has some lubricant and disintegrant properties 
which is useful in direct tableting. Small amounts of MCCs are able to efficiently 
bind other materials, especially poorly tabletable active pharmaceutical ingredi-
ents. MCC exhibits a high dilution potential, whereas the broad particle size range 
provides optimum packing density and coverage of other materials [44, 54].
MCC has been the most favorite diluent among others due to its low bulk 
density. Excipient having low bulk density and large particle size distribution will 
exhibit a high dilution potential on a weight basis, optimum packing density, and 
coverage of drug and other excipient materials [77].
MCC is commercially available in different particle sizes, density, and moisture 
grades that have different properties and applications. The most widely pronounced 
grades are Avicel PH 101 and Avicel PH 102 (FMC Corporation, Princeton, NJ, 
USA). PH stands for the pharmaceutical grade of MCC. Avicel PH 101 is the original 
grade of MCC, while PH 102 is available as a partially agglomerated product with 
a larger particle size distribution and slightly better fluidity. Both grades show no 
significant difference in the compressibility [78].
4.1 MCC as directly compressible filler
MCC has been very well known as the most compressible of all direct compres-
sion fillers which has the highest dilution potential and capacity. It is defined as the 
amount of active ingredient that a diluent can successfully carry in the direct com-
pression method. This property can be explained by the basis of the physicochemi-
cal nature of MCC particles, which are held together by hydrogen bonds. MCC 
particles are deformed plastically under compaction forces to yield an extremely 
large number of clean surfaces brought in contact during this deformation, forming 
a strong compact even under low compression forces [78].
Direct compression (DC) is the tableting process of a blend of ingredients 
without a preliminary granulation or agglomeration process. Despite involving only 
few process steps, product design in DC can be challenging because of the numer-
ous competing objectives [79]. Direct compression requires increased performance, 
quality, and consistency from the starting ingredients including excipients [44, 56, 
80, 81]. The use of poorly controlled or inadequately specified raw materials may 
lead to several challenges in DC, such as poor flowability and inconsistent tablet 
weight, unsatisfactory tablet strength, lack of content uniformity or segregation, 
and dissolution failure [56, 82, 83]. Among several requirements, the compression 
mix has to flow to ensure a consistent tablet weight; it has to compress and compact 
into robust tablets. Overall, as a direct compression filler, Avicel promotes efficient 
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dry blending of ingredients and produces tablets with high hardness levels and low 
friability levels with excellent compression. It produces tablets of superior white-
ness and color stability.
Lately, MCC can be considered as the most widely used diluent in the direct 
compression and wet granulated tablet making procedures. MCC type 102, having 
a median particle size of about 100 mm (D50 value measured by laser diffraction), 
presents acceptable flow properties required for successful high-speed tableting 
[2, 84]. However due to the low bulk density of MCC, its mass flow is less than 
that of other common and denser excipients such as direct compression grades of 
lactose or dibasic calcium phosphates [43, 44, 59, 82]. Avicel grades (Avicel PH-102 
SCG, Avicel HFE-102, Avicel PH-200, Avicel PH-302) provide excipient solutions 
to many challenges of direct compression formulations including improved flow, 
better compressibility, and accommodation of moisture-sensitive actives [78]. The 
larger particle size grades generally provide better flow properties, while low-
moisture grades are used for moisture-sensitive materials. Higher-density grades 
have improved flowability. Flowability may be improved by selecting coarser grades 
of MCC with a larger number of aggregates, such as MCC type 200 with a median 
particle size approximating 200 mm [58, 85].
The difference between these common excipients is less pronounced on a 
volumetric basis [86], which determines die fill. Another approach may be to 
combine MCC with other free flowing excipients or glidants [59, 62, 87]. Gamble 
et al. observed that the particle size distributions of coarser grades of MCC do not 
scale up proportionally [58]. MCC types 101, 102, and 200 all have primary particles 
of about 50 mm but differ in the number of larger aggregated particles. These 
aggregates, accounting for a large volume/mass fraction but a low number fraction, 
enable improved flow.
During compression, MCC plastically deforms and therefore maximizes the 
area of interparticle bonding [88]. Mechanical interlocking of irregularly shaped 
and elongated MCC particles has also been suggested to enhance tabletability 
[44, 60, 75]. The plasticity of MCC is the main reason of its exceptional bind-
ing properties. However, compared to brittle excipients, MCC is more lubricant 
sensitive. For a constant number of revolutions, tabletability may also decrease 
with increasing blender sizes and decreasing loadings in the blender [89]. The 
viscoelastic behavior of MCC also explains its strain rate sensitivity (SRS), which 
refers to the greater elastic effects at higher tableting speeds where there is insuf-
ficient compaction time for plastic deformation [90]. The strain rate sensitivity of 
viscoelastic excipients has to be taken into account by the formulation scientists in 
order to design robust formulations.
4.2 MCC as wet granulation filler
MCC is one of the types of filler which is water insoluble having swelling ten-
dencies and excellent water imbibing or wicking action. Other filler examples with 
the same property are calcium pectinate and sodium alginate. This property makes 
MCC as also an excipient of choice for wet granulation. Both Avicel PH 101 and 
Avicel PH 102 can be used advantageously as fillers in wet granulation in a concen-
tration of 5.15%. When used as filler in wet granulation method, the wicking action 
of MCC promotes rapid wetting of the powder mix. Another advantage offfered 
by using MCC as wet granulation filler is the ability to retain water, which makes 
the wet mass less sensitive to overwetting due to an excess of granulating fluid. The 
milling of the wet mass will be much easier due to less clogging of the screen; hence 
it will produce a more uniform granules. Drying process also will be more homoge-
neous, and the case of hardening can be reduced. Case hardening is a phenomenon 
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which is observed in incompletely dried granules. This case happened when the 
granules are dried at a high temperature, from which the inside part of the granules 
remains wet, while the surface seems dried. The granules are often hard and resist 
disintegration. When coming to compaction process, the compression forces will 
break the granules and deform plastically to form soft tablets due to the moisture 
coming out of the incompletely dried granules. The use of Avicel PH 101 or Avicel 
PH 302 as filler in wet granulation promotes rapid wetting as a result of the wicking 
action of MCC. They reduce sensitivity of the wet mass to overwetting and increase 
the drying process speed. Since there is fewer excess of granulating fluid, screen 
blockages and case hardenings can be reduced. Homogeneous and uniform granule 
when MCC is used as wet granulation filler will reduce dye migration. When MCC 
is employed, faster disintegration from granules and tablets will be obtained.
4.2.1 Benefits of MCC in wet granulation
Basically, using MCC in wet granulation included wetting MCC with water 
followed by drying and compression. The process resulted in lower hardness 
tablets than that with dry compression. The wet granulation reduces the density of 
agglomerated particles thereby decreasing their internal surface area. In contrast, 
it can also cause adhesion between particle agglomerates, reducing external surface 
area resulting in less particle interlocking and hydrogen bonding. In general, using 
Avicel PH-101 or Avicel PH-102 in wet granulation formulations with concentration 
between 5 and 20% offers the following benefits [51]:
1. Rapid adsorption of water by MCC and distribution through the mixture
2. Decrease of sensitivity to water content, wet screening, and localized overwet-
ting due to the large surface area of MCC, hence high adsorptive capacity
3. Increased drying efficiency
4. Decreased color mottling
5. Better drug content uniformity
6. Higher tablet hardness at the same compression force with less friability
4.3 Filler in dry granulation
Roller compaction is a dry process involving compaction of materials that are 
then milled to generate a granulation. This granulation is then lubricated and 
compressed on a tablet machine. This process can be used for moisture-sensitive 
active pharmaceutical ingredients. The use of Avicel PH grades in roller compaction 
includes improvement of compaction in the ribbon phase, enhancement of flow of 
the granules, and preserving of the content uniformity of the Þ nal granulation.
4.4 MCC as binder
MCC is a self-disintegrating binder [91] with low lubricant requirement with 
regard to its dry binding properties due to the extreme low coefficient of friction 
and its very low residual die wall pressure [56, 62, 92]. However these properties do 
not replace the need for true disintegrants and lubricants as an addition when MCC 
is used in a tablet formulation. In fact combination of MCC and superdisintegrants 
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may be complementary to promote fast disintegration [93, 94]. Other advantages of 
MCC include broad compatibility with various APIs, physiological inertness, ease 
of handling, and ease of supply for manufacturer [54].
Study on the use of MCC with spray-dried lactose as the poorest compressibility 
among all directly compressible fillers showed that a blend of 200 mg of spray-
dried lactose with appropriate lubricants may not be able to compress unless a cor-
rect amount of dry binder is incorporated inside the blend. Incorporation of 2.5% 
of Avicel to the formulation proved that MCC has served the purpose. A number of 
Avicel such as PH-113 can act as a dry binder [95]. However, it will also function as a 
disintegrant when dry compression is employed.
4.4.1 MCC as a wet binder
MCC can also be used as a secondary binder in wet granulation tablet prepara-
tion either to granulate both soluble and insoluble APIs. This formulation will 
produce less hard tablets than that without MCC. The fast wicking action of MCC 
promotes rapid wetting of the powder mix. This is particularly useful in high 
moisture granulations as it binds the excess moisture and keeps the granules dry 
and free flowing.
4.5 MCC as disintegrant
Disintegrants expand and dissolve once it is in contact with water causing the 
tablet to break apart in the GI tract and release the active ingredients for absorption. 
It will break a tablet into smaller fragments therefore increasing the surface area 
of the active drug in the dosage form; hence it will also increase the rate of drug 
absorption. The mechanism of disintegrants in the tablet disintegration could be as 
either water uptake facilitators or tablet rupture promoters. MCC has been widely 
used as a disintegrant in dry compressions and wet granulation method for tablet 
manufacturing. It enhances drug dissolution by increasing the rate of tablet disin-
tegration. Basically a disintegrant should provide the highest level of disintegration 
force at low use levels and utilizes dual disintegration mechanisms either in wicking 
or swelling for faster tablet disintegration.
The Avicel derivate showed the nature in a fast wicking rate of water with small 
elastic deformation. These properties provide the ability for tablet disintegration. 
However, Avicel has a tendency to develop static charges with increased moisture 
content. Sometimes it even can cause striation or separation in the granules. This 
occurs when the moisture content in Avicel is above 3%, in which the static charges 
during mixing and compression become more pronounced. The problem can be 
overcome by drying the Avicel prior the formulation process to reduce the moisture 
to lower level. Wet granulated Avicel will lose some of its disintegration properties 
when performing drying and compression during formulation [4]. In contrast with 
starch, it cannot be wet granulated without losing some of its disintegration proper-
ties. Normally, to overcome this problem, Avicel and starch are used in combination 
in order to facilitate effective and rapid disintegration of tablets.
MCC has a very high intraparticle porosity with approximately 90–95% of the 
surface area being internal [44]. Therefore the surface area is not directly influenced 
by the nominal particle size [58]. High porosity of MCC promotes swelling and 
disintegration of formulated tablets, which is attributed to either by the penetration 
of water into the hydrophilic tablet matrix by means of capillary action of the pores 
or even by a disruption of the hydrogen bonds. By increasing compaction pressure, 
water penetration into the tablets will decrease; therefore disintegration time will 
increase [54, 85].
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In intramolecular view, water is only sorbed in the amorphous regions of MCC, 
which are more hydrophilic than the crystalline regions [3, 54]. Therefore the total 
amount of sorbed water is proportional to the fraction of amorphous material in the 
MCC crystallinity and is independent of the surface area [48]. The crystallinity of 
MCC determined by X-ray diffraction and infrared measurement was found to be 
in the range of 60–80% [53].
Recently, Avicel has been used as a disintegrant in orally disintegrating tablets. 
Besides being a disintegrant, it also acts as a dissolution enhancer. US Patent No 
6350470 explains the use of Avicel as a disintegrating agent in effervescent drug 
delivery system for oral administration. In this system, by performing dry granula-
tion, Avicel acts as disintegrant in a concentration of 5.20% [96]. Avicel acts as an 
effervescent penetration enhancer.
4.6 MCC as lubricant
Lubricants ensure that tablet formation and ejection can occur with low friction 
between the solid and die wall.
Avicel has an extremely low coefficient of friction, both static and dynamic, so 
that it has no lubricant requirement itself. However, when more than 20% of the 
drug and other excipients are added, lubrication is necessary.
4.7 MCC as glidant
In tablet formulation, glidant is used to promote powder flow by reducing inter-
particle friction and cohesion. Glidants can be used in combination with lubricants 
as they have no ability to reduce die wall friction. Normally, silica-based glidants 
like silicon dioxide, hydrated sodium silicoaluminate, silica hydrogel, etc. are used 
in tablet compression to promote good flow property. Proslov as a marketed product 
of coprocess excipient containing MCC is available which imparts superior flow, 
good compactibility, and dispersion to tablet formulation [97].
When used as excipient in direct compression, Prosolv SMCC® (JRS Pharma, 
Patterson, NY) can replace granulation step and significantly reduce excipient 
numbers and levels. Prosolv SMCC® formulations produce distinctive, uniform, 
and cost-effective tablets. It is available in three grades: Prosolv SMCC 50, Prosolv 
SMCC 90, and Prosolv SMCC HD 90. The products differ in average of particle 
size and bulk density [98]. They offer many benefits including enhanced mixing 
characteristics, enhanced flow properties, lower unit cost of production due to less 
excipients needed, and shorter disintegration time. Due to improvement in powder 
compactibility and dust-free handling during production, Prosolv facilitates less 
loss in production hence a higher manufacturing efficiency.
In a more recent study, it is reported that silicified MCC and MCC were found 
to be good plug formers in hard gelatin capsule shells. The study was conducted in 
a compaction simulator at tamping forces and piston speeds similar to those found 
in some filling machines. Several grades of silicified MCC and a particular grade 
of MCC having particle size of 90 μm produced plugs with a higher maximum 
breaking force than anhydrous lactose and Starch 1500 under similar compression 
conditions [99].
4.8 MCC as a spheronizing agent
MCC is an excipient of choice in a multiparticulate delivery of pellets prepared 
by extrusion spheronization. The extrusion-spheronization process aims to pro-
duce drugs into sphere-shaped tablets. Extrusion-spheronization process offers an 
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alternative to traditional drug layering on pellets. This highly specialized process 
results in unique spherical, drug-loaded spherical pellets. Higher drug loading can 
be employed with this approach over that which looks impossible with conventional 
drug layering. The product, initially called as extrudates, is plastic without rigidity, 
which tends to agglomerate into very large spherical balls. The formulation mixture 
which will be manufactured by extrusion method must fulfill the requirements:
1. Cohesive and deformable in order to have good flow through the die without 
sticking and able to retain its shape after extrusion process
2. Plastic, so that it can proceed rolling process into spheres in the spheronizer 
but possesses non-cohesive property so that the final sphere form can remain 
discrete
MCC, especially Avicel PH-101, can act as an excellent extrusion-spheronization 
aid excipient that absorbs the water added to the formulation more as a molecular 
sponge. This ability alters the rheological properties of the wet mass, therefore 
enhancing the tensile strength of the wet mass during spheronization process 
through autoadhesion.
Avicel® PH-101 or Avicel PH-102 is highly recommended to be used for this 
method because it can reduce spheroid friability, prevent overwetting of spheres, 
and improve sphericity of pellets. Process sensitivity during the whole manufacture 
can be lessened to the lower level.
4.9 Sustained release applications
Recently, MCC has been widely used in the formulation of multiparticulate and 
matrix tablet dosage forms for sustained release drug delivery system. In general, 
hydrophilic polymers in matrix tablet formulation are included to form a viscous, 
gelling layer which can retard water penetration and acts as a barrier to drug release. 
Drug release is accomplished by diffusion through the gel layer and at the same time 
through erosion of this layer. Some studies proved that zero-order release profiles 
can be achieved by selection of appropriate polymers in addition of Avicel as fillers/
binders.
5. Conclusions
Microcrystalline cellulose is a pure partially depolymerized cellulose synthesized 
from α-cellulose precursor with hydrolysis by mineral acids, usually in forms of 
a pulp from a fibrous plant. In the presence of water and acid, hydrolysis process 
breaks cellulose polymers into smaller chain polymers or microcrystals. Other cellu-
loses, to which more soluble, such as beta and gamma celluloses, hemicelluloses and 
lignin are dissolved with acid and water, are separated out during washing. MCC is 
commonly dried from the slurry by spray-drying method. By varying spray-drying 
conditions, the degree of agglomeration and moisture content can be manipulated, 
in order to obtain particular particle sizes.
Mostly, a raw material for MMC is a cellulose pulp from fibrous plant such 
as conifer wood. Another source is from cotton either its linters, stalks, rags, 
fabric waste, or wool. Another study reported a potential source for MCC such as 
soybean, corn cob, water hyacinth, coconut shells, oil palm biomass residue, oil 
palm fronds, rice husk, sugar cane bagasse, jute, ramie, fibers and straw of flax, 
wheat straw, sorghum stalks, sisal fibers, mangosteen, alfa grass fibers, soybean 
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hulls, orange mesocarp, Indian bamboo, roselle fiber, and alfa fiber. Seed flosses 
from milkweed pods, shrubs, and kapok (Ceiba pentandra) trees are also known as 
sources of cellulose.
A different manufacture will produce variability in properties of MCC due to 
the kinds of pulp used as raw materials and applied process parameters. This can be 
characterized from the physicochemical properties of product including moisture 
content, particle size, particle morphology, crystallinity, bulk density, and degree of 
polymerization.
Microcrystalline cellulose, according to many publications, is an excipient most 
widely used for direct compression. Besides, it also serves as a strong dry binder, 
tablet disintegrant, absorbent, filler or diluent, a lubricant, and anti-adherent.
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